Clinical Trials Directory

Trials / Completed

CompletedNCT02540031

The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy

The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy in Patients Showing Brown Effluents

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
156 (actual)
Sponsor
Kyungpook National University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Although adequate bowel preparation is essential for successful colonoscopy, the 23% of patients had shown inadequate bowel preparation. Inadequate bowel preparation may results in incomplete examination, increased patient's discomfort, decreased polyp detection rates, ultimately leading to repeated colonoscopies. One prior study showed that patients reporting their last rectal effluents as brown color or solid stool had a 54% chance of having fair or poor preparation. Thus, recent consensus guideline suggested consideration of additional oral preparation in patients presenting brown effluents on the day of colonoscopy. However, the data supporting additional oral preparation is still spares. Therefore, the investigators aimed to examine the impact of additional oral preparation on the quality of bowel preparation for colonoscopy in patients showing brown effluents on the day of colonoscopy.

Conditions

Interventions

TypeNameDescription
DRUGAdditional oral preparation (3L of PEG+Asc, "Coolprep®")The interventional or experimental arm will receive 1l of additional PEG+Asc, "Coolprep®" on the day of colonoscopy \* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g
DRUGStandard oral preparation (2L of PEG+Asc, "Coolprep®")The control arm will receive currently used oral preparation (2l of PEG+Asc, "Coolprep®") for colonoscopy \* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g

Timeline

Start date
2015-09-01
Primary completion
2018-04-01
Completion
2018-06-01
First posted
2015-09-03
Last updated
2018-07-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02540031. Inclusion in this directory is not an endorsement.

The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy (NCT02540031) · Clinical Trials Directory